GlaxoSmithKline Nigeria Profit Little Changed as Revenue Climbs

GlaxoSmithKline Nigeria (GLAXOSMI) Plc posted net income of 1.672 billion naira for the nine months to Sept. 30, little changed from 1.668 billion naira a year earlier.

Revenue for the period climbed to 15.84 billion naira from 12.8 billion naira, the company said in a statement published on the website of the Nigerian Stock Exchange today.

To contact the editor responsible for this story: Alastair Reed at areed12@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.